Articles
Biotechnology Conference: Can Regenerative Medicine Improve the Way We Live, Play, and Feel?
The College of Engineering and Computing Sciences hosted industry at experts at the 2023 Biotechnology Conference, where they discussed innovations in regenerative medicine and ways to improve the human condition.
Advocates for Womens Health
Meet eight 雅伎著 faculty and students who are making strides to improve womens healthcare.
Turning the Tables on Consumers
A study co-authored by marketing researcher Colleen Kirk, D.P.S., explores what happens when sellers review consumers.
Faculty Profile: Andrew Hofstrand
Assistant Professor Andrew Hoftstrand, Ph.D., will use an Air Force Research Laboratory/Air Force office of Scientific Young Investigators Program Award to study light-matter interactions and ways to control and manipulate it with the hope of creating faster and more efficient technologies.
The Scent of Discovery
New research from the College of Osteopathic Medicine (NYITCOM) could help explain how the sense of smell is impacted in individuals with autism.
A Quest for Bacterial Assassins
The College of Arts and Sciences Bryan Gibb, Ph.D., and undergraduate Hamza Nawargala are working on research to combat antibiotic-resistant infections.
Recognizing American Heart Month
In recognition of American Heart Month, 雅伎著 News is looking back at select highlights of NYITCOMs esteemed cardiovascular research, awards, and public education efforts.
Keeping Science on Its Toes
In a study published by PeerJ, Professor Nikos Solounias, Ph.D., and NYITCOM student Shannon Smith explain why a bony structurewhich they dub the bony capmay play a large role in finger and toe regeneration and nail growth.
A Research Collaboration with Heart
NYITCOM and the DeMatteis Center for Cardiac Research and Education have forged a new collaboration that enables medical students to join in innovative and potentially life-saving research.
NIH-Funded Research at NYITCOM Could Yield New Brain Disorder Treatments
NYITCOMs Jerry Zhao, Ph.D., has secured an NIH grant in support of research that could help to deliver new drugs to treat Alzheimer’s disease, Parkinson’s disease, and autism spectrum disorder.